Please assess the completion status of the following clinical trial:

Trial Title: Steroids in Children Hospitalized With Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Signed informed consent by legal guardian~* Age 2 to 18 years old~* Admission to the floor with acute asthma exacerbation.~* Received single dose of oral Dexamethasone~* Initial Pediatric Asthma Score (PAS) of 8 or higher.~Exclusion Criteria:~* Admission to PICU~* Recent steroid use (within 1 month)~* Cardiac disorder, chronic respiratory illness (BPD or CF)~* Stridor~* Bacterial Pneumonia

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Dexamethasone (Type: EXPERIMENTAL): Dexamethasone arm: will receive second dose of oral Dexamethasone 0.6 mg/kg/dose max of 16 mg, 24 hour from the first dose given in emergency department.
- Prednisone (Type: ACTIVE_COMPARATOR): Prednisone arm: will receive oral Prednisone 1mg/kg with max of 30 mg twice daily starting 24 hours after the Dexamethasone dose given in emergency department for 8 additional doses.

Based on this trial design, predict the completion outcome and termination type (if applicable).